Telemedicine Visit
Sponsors
NYU Langone Health, Wake Forest University Health Sciences, Cedars-Sinai Medical Center, Vanderbilt-Ingram Cancer Center, City of Hope Medical Center
Conditions
Astrocytoma, IDH-MutantCovid19Diffuse Large B Cell LymphomaDiffuse Large B-cell LymphomaEnd Stage Renal DiseaseFollicular LymphomaGastric CarcinomaGastroesophageal Junction Adenocarcinoma
Phase 4
Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting
CompletedNCT05108805
Start: 2021-12-02End: 2023-12-08Updated: 2025-03-27
Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
CompletedNCT06625047
Start: 2024-10-07End: 2025-11-12Updated: 2026-04-29
Unknown Phase
Feasibility Study of Telemedicine for Dialysis Patients Awaiting Transplantation
CompletedNCT03189212
Start: 2017-10-01End: 2021-01-19Updated: 2023-01-12
Telemedicine for Early Detection of Cytokine Release Syndrome and Neurotoxicity
WithdrawnNCT04503538
Start: 2020-12-31End: 2023-11-30Updated: 2020-10-23
Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic
CompletedNCT04652674
Start: 2020-09-28End: 2022-06-30Updated: 2022-12-27
Telehealth for the Self-Management of Dietary Quality of Life in Patients After Stomach Cancer Surgery
Active, not recruitingNCT05203627
Start: 2020-01-21End: 2026-10-01Updated: 2026-08-19